AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2011
Dec 12, 2011
35124_dirs_2011-12-12_706f1e25-3440-4928-b4b3-b0d6aa04c240.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-12-12
Reporting Person: Borys Nicholas (CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-12 | Celsion Corporation Common Stock | P | 5000 | $1.999 | Acquired | 35687 | Direct |
Footnotes
F1: The Executive purchased the shares of common stock on the open market.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23